Photo from docwirenews.com
Oct 7, 2024, 16:46
Outcomes in patients with oligoprogression following 1st line IO or ChemoIO
Gerry Hanna, Radiation Oncologist at St James’s Hospital, shared a post on X:
“Very intresting paper by Lauren Julia Brown, Harriet Gee, Eric Hau from Australia. They report outcomes in patients with oligoprogression following 1st line IO or ChemoIO.
Patients who receive radiotherapy have better survival.
Paper link on JTO & JTO CRR.”
Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study
Authors: Lauren Julia Brown, et al.
Source: Gerry Hanna/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29
Nov 13, 2024, 15:25
Nov 13, 2024, 14:55
Nov 13, 2024, 14:47
Nov 13, 2024, 14:43
Nov 13, 2024, 14:37
Nov 13, 2024, 14:05